Background: Retinol and its derivatives (retinoids), which have antioxidant activity and promote cell differentiation, may protect against the development of hepatocellular carcinoma (HCC) by controlling hepatocellular differentiation and re ducing infl ammatory responses. Methods: We examined prospectively the relationship between prediagnostic serum concentrations of retinol, α -carotene; β -carotene; β -cryptoxanthin; lutein; lycopene; zeaxanthin; α -, γ -, and δ -tocopherols; and selenium and the risk of developing HCC among 213 patients with HCC and 1087 matched control subjects from a cohort of 18 244 men in Shanghai, China, who were monitored from 1986 through 2001. Odds ratios (ORs) and 95% confi dence intervals (CIs) for men by quartile of serum concentrations of micronutrients were estimated by using logistic regression with adjustment for cigarette smoking status, alcohol intake, self-reported history of physician-diagnosed hepatitis or liver cirrhosis at recruitment, and seropositivity for hepatitis B surface antigen (HBsAg). All statistical tests were two-sided. Results: Men with high prediagnostic serum retinol levels had a lower risk of HCC than men in the lowest quartile (Q2 versus Q1, OR = 0.37, 95% CI = 0.22 to 0.61; Q3 versus Q1, OR = 0.30, 95% CI = 0.17 to 0.50; and Q4 versus Q1, OR = 0.13, 95% CI = 0.06 to 0.26; P trend <.001). A statistically significant interaction was observed between retinol and HBsAg seropositivity on HCC risk; HBsAg-positive men in the lowest tertile of retinol had a greater than 70-fold higher risk (OR = 72.7, 95% CI = 31.6 to 167.4) of HCC than HBsAgnegative men in the highest tertile of retinol ( P interaction = .018). No independent effect of serum levels of α -carotene; β -carotene; β -cryptoxanthin; lutein; lycopene; zeaxanthin; α -, γ -, and δ -tocopherols; or selenium on HCC risk were observed.
Chronic infection with hepatitis B virus (HBV) is by far the most important risk factor for hepatocellular carcinoma (HCC) in humans and is the primary cause of this cancer in high-risk areas, including China and Africa ( 1 , 2 ) . Chronic infection with hepatitis C virus (HCV) is another risk factor for HCC and has an increasingly prominent role in the development of HCC in countries where rates of infection with HBV are relatively low ( 3 ) . Other environmental risk factors for HCC include dietary afl atoxin, which plays a prominent role in high-risk areas such as China and Africa; excessive alcohol intake; cigarette smoking; diabetes; and obesity ( 4 -6 ) .
Carcinogenesis is characterized by aberrant cell differentiation ( 7 ) . Retinol and its derivatives (retinoids) have vital roles in controlling cellular growth and differentiation ( 8 ) . Retinoids have been shown to inhibit the transformation (activation) of hepatic stellate cells ( 9 ) and to suppress the proliferation of human hepatoma cells ( 10 ) . Retinol has also been shown to inhibit the formation of afl atoxin B 1 (AFB 1 ) -DNA adducts in hepatocytes ( 11 ) , a crucial step in afl atoxin-induced hepatocarcinogenesis, and to inhibit the development of preneoplastic lesions in the liver of rats treated with chemical carcinogens ( 12 ) . Persistent infl ammation caused by chronic infection with HBV and/or HCV is believed to be one mechanism of hepatocarcinogenesis and is probably mediated by infl ammatory cytokines ( 13 ) . Retinoids inhibit the production of proinfl ammatory cytokines in cultured macrophages and reduce infl ammatory reactions ( 14 ) . Reactive oxygen species induced by chronic infl ammation can cause damage to DNA, proteins, and lipids. Reactive oxygen species -induced DNA damage is believed to be directly involved in hepatocarcinogenesis ( 15 , 16 ) . Antioxidants, such as retinol and carotenoids, can neutralize reactive oxygen species and can possibly prevent the development of HCC. Several antioxidants, including β -carotene, vitamin E, and selenium, have been shown to inhibit chemically induced liver cancer in rodents ( 17 -19 ) .
Prospective epidemiologic studies of serum retinol and other antioxidants in relation to HCC risk are scarce. In this study, we examined the relationship between concentrations of antioxidant micronutrients in prediagnostic serum samples and the risk of developing HCC in a Chinese cohort in Shanghai, China, after 15 years of follow-up. Micronutrients measured included retinol, specifi c carotenoids ( α -carotene, β -carotene, β -cryptoxanthin, lutein, lycopene, and zeaxanthin); α -, γ -, and δ -tocopherols; and selenium.
S UBJECTS AND M ETHODS

Study Population
The design of the Shanghai Cohort Study has been described in detail elsewhere ( 20 , 21 ) . In brief, 18 244 men (approximately 80% of the eligible subjects) aged 45 -64 years and had no history of cancer at recruitment were enrolled in the study between January 1, 1986, and September 30, 1989 . Participants were interviewed in person by using a structured questionnaire to obtain information on demographic characteristics, use of tobacco and alcohol, usual adult diet, and medical history. At completion of the interview, a 10-mL nonfasting blood sample was collected from each participant. Multiple aliquots of serum from each study subject were then stored at − 70 °C. Written informed consent was obtained from surviving participants at follow-up in 1997. The institutional review boards at the University of Southern California, the University of Minnesota, and the Shanghai Cancer Institute approved this study on an ongoing basis.
At recruitment, we asked each participant whether he had ever been told by a physician that he had any of the following diseases: hepatitis (infectious, serum, or unknown type), liver cirrhosis, other liver disease, diabetes, gastric ulcer, duodenal ulcer, gallstones, other gallbladder conditions, tuberculosis, high blood pressure, asthma, emphysema, hemorrhoid, diverticulosis, polyposis coli, ulcerative colitis, adenomatous polyps, schistosomiasis, other parasitic diseases, or cancer. If the answer was yes, he was asked to provide the year of the fi rst diagnosis and the treatment for each disease. We also asked each participant whether he had ever drunk alcoholic beverages at least once a week for 6 months or more. If the answer was yes, he was asked to provide the typical amount of beer, wine, and/or spirits (each) consumed. One drink was defi ned as 360 g of beer (12.6 g of ethanol), 103 g of wine (12.3 g of ethanol), or 30 g of spirits (12.9 g of ethanol) ( 22 ) . Smokers were identifi ed as men who smoked at least one cigarette per day for 6 months or more.
Case Patients
Incident cancer cases and deaths among cohort participants through December 31, 2001 , were identifi ed through routine reviews of reports from the population-based Shanghai Cancer Registry and the Shanghai Municipal Vital Statistics Offi ce and by annual in-person re-interviews of surviving cohort members. A total of 422 (2.3%) cohort participants were lost to follow-up as of December 31, 2001 .
As of December 31, 2001 (this study's cutoff date), the study had accumulated 229 966 person-years of observation. A total of 214 cohort participants who were free of cancer at recruitment had developed liver cancer. These 214 HCC case patients were diagnosed by histopathologic analysis (n = 39), elevated serum α -fetoprotein with consistent clinical and radiologic history (n = 53), positive computerized axial tomography scan and/or ultrasonography with consistent clinical history (n = 115), or by death certifi cate only (n = 7).
Control Subjects
For each case patient, multiple cancer-free control subjects, who were individually matched to the index case patients by date of birth (within 2 years), date of blood collection (within 1 month), and neighborhood of residence at recruitment, were randomly chosen from the cohort. Ten control subjects were matched to each of the fi rst six identifi ed case patients with HCC, and fi ve control subjects were matched to each of the remaining 208 case patients.
Laboratory Tests
Serum samples in each matched set (the case patient and his matched control subjects) were arranged in random order, identifi ed only by unique codes, and assayed in the same batch for all laboratory measurements. Test samples were processed in a dim room to avoid potential change in chemical structures of retinol and certain carotenoids by strong light. Serum concentrations of α -carotene; β -carotene; β -cryptoxanthin; lutein; lycopene; zeaxanthin; retinol; and α -, γ -, and δ -tocopherols were determined by high-performance liquid chromatography using methods described previously ( 23 ) . Serum selenium concentrations were measured by Zeeman graphite atomic absorption spectrophotometry ( 24 ) . The within-batch coeffi cients of variation were 0.8% for retinol, 1.3% for selenium, and 2.6% -5.7% for the other micronutrients measured. The between-batch coeffi cients of variation were 3.9% for retinol, 2.3% for selenium, and 4.4% -13.3% for other micronutrients.
We also tested all study samples for the presence of hepatitis B surface antigen (HBsAg), using a standard radioimmunoassay assay (AUSRIA; Abbott Laboratories, Abbott Park, IL). Assays for the antibodies to HCV and urinary biomarkers of dietary exposure to afl atoxin were described previously ( 20 , 25 , 26 ) .
One case patient and eight control subjects had missing serum retinol and carotenoid measurements. Thus, this study included 213 case patients and 1087 control subjects.
Statistical Analysis
The distributions of all serum micronutrients investigated were markedly skewed toward high values. Therefore, formal statistical testing was performed on logarithmically transformed values, and geometric (as opposed to arithmetic) means are presented. We used the analysis-of-covariance method ( 27 ) to compare differences in serum concentrations of micronutrients between control subjects who were 1) smokers and nonsmokers, 2) alcohol drinkers and nondrinkers, and 3) positive and negative for HBsAg serology. We also used analysis-of-covariance method to compare the differences in serum concentrations of micronutrients between HCC case patients and their matched control subjects.
We used standard statistical methods to analyze data from matched case -control sets ( 28 ) . Conditional logistic regression models were used to calculate odds ratios (ORs) and their corresponding 95% confi dence intervals (CIs) and P values. Study subjects were grouped into tertiles or quartiles based on the distributions of serum micronutrients among all control subjects (Supplementary Table 1 ; available at http://jncicancerspectrum. oxfordjournals.org/jnci/content/vol98/issue7 ). The linear trend test for the association between serum concentrations of micronutrient and HCC risk was based on ordinal values.
To evaluate the effect of a micronutrient independent of other nutrients on HCC risk, we used two approaches: 1) a multivariable logistic regression model with other nutrients as covariates and 2) subgroup analyses in subjects stratifi ed by tertile levels of other nutrients. To examine whether the combined effect of retinol and HBsAg with HCC risk was greater than the multiplicative product of their individual effects, we used a conditional logistic regression model that simultaneously included the product term and the main effect terms of the two variables. To adjust for potential confounding effects of other identifi ed risk factors on the association of specifi c nutrients with HCC risk, we included the following variables in multivariable logistic regression models: cigarette smoking (nonsmokers or ever smokers), heavy alcohol consumption (<4 drinks/day including nondrinkers or ≥ 4 drinks/day), self-reported history of physiciandiagnosed hepatitis or liver cirrhosis at recruitment (no or yes), and HBsAg seropositivity (negative or positive). For all stratifi ed analyses, matched sets were broken and unconditional logistic regression models were used. The original matching factors (age, year of blood collection, and neighborhood of residence at recruitment) were adjusted for in all analyses on unmatched data sets.
Statistical analyses were performed using the SAS version 9.1 (SAS Institute Inc., Cary, NC) and Epilog windows version 1.0 (Epicenter Software, Pasadena, CA) statistical software packages. All P values are two-sided. P <.05 was considered statistically signifi cant.
R ESULTS
We fi rst compared the distributions of selected demographic, lifestyle, and risk factors of case patients with control subjects.
The mean age (± standard deviation) of case patients (n = 213) at diagnosis of HCC was 63.5 (±5.8) years, and the mean age of control subjects (n = 1087) at the time of HCC diagnosis of the matched case patients was 63.4 (±5.7) years. The average time interval between blood draw and cancer diagnosis among case patients was 6.9 (±3.8) years (range = 1 month to 15.8 years). The case patients and control subjects had similar mean body mass indices (22.0 versus 22.2 kg/m 2 ; P = .31). Cigarette smoking, heavy alcohol consumption ( ≥ 4 drinks/day), self-reported history of physician-diagnosed hepatitis or liver cirrhosis, HBsAg seropositivity, and exposure to dietary afl atoxin were risk factors for HCC in the study population ( Table 1 ) . As previously reported ( 25 ) , the role of HCV infection in HCC development in this study population was negligible; only one of 76 case patients and one of 405 control subjects tested positive for the antibodies to hepatitis C virus. One (0.5%) case patient and nine (0.8%) control subjects reported a history of physiciandiagnosed diabetes.
In this study, alcohol drinkers had a statistically signifi cantly higher level of circulating retinol than nondrinkers ( Table 2 ) . Therefore, adjustment for serum retinol concentration was made in the analysis of the association between alcohol intake and HCC risk. Before adjustment for retinol, the odds ratios for HCC * Odds ratios (ORs) were calculated by using conditional logistic regression models that retained a matched set consisting of fi ve to 10 control subjects who were individually matched to the index case patient by date of birth (within 2 years), date of blood draw (within 1 month), and neighborhood of residence at recruitment. CI = confi dence interval.
† Adjusted for serum level of retinol, P trend = .016. ‡ Serology of the antibodies to hepatitis C virus (anti-HCV) was determined for 76 patients and for 405 control subjects.
§ Urinary afl atoxin biomarkers including afl atoxin B 1 (AFB 1 ), its metabolites AFM 1 and AFP 1 , and AFB 1 -N 7 -guanine adduct (AFB 1 -N 7 -Gua) were determined for 50 patients and 265 control subjects.
lycopene, and zeaxanthin than those of HBsAg-negative subjects ( Table 2 ) .
We compared serum levels of micronutrients for HCC case patients with those of control subjects. Overall, case patients had statistically signifi cantly lower geometric means of retinol, β -carotene, β -cryptoxanthin, and α -and γ -tocopherol than did control subjects after adjustment for HBsAg seropositivity, history of hepatitis or liver cirrhosis at recruitment, heavy alcohol consumption, and cigarette smoking ( Table 3 ) . After exclusion of HBsAg-positive subjects, the differences in levels of retinol and β -carotene between the case and control subgroups remained statistically signifi cant ( Table 3 ) . Further exclusion of subjects with a positive history of hepatitis or liver cirrhosis did not materially change the results (data not shown). The geometric means of all other micronutrients measured were not statistically signifi cantly different between case patients and control subjects ( Table 3 ) .
We examined the association between quartile levels of prediagnostic serum micronutrients and HCC risk. Before adjustment for potential confounders, increased serum levels of retinol; α -and β -carotene; and α -, γ -, and δ -tocopherol were associated with statistically signifi cantly reduced risk of HCC (all P trend <.05, Table 4 ). After adjustment for HBsAg seropositivity, selfreported history of physician-diagnosed hepatitis or liver cirrhosis at recruitment, heavy alcohol consumption ( ≥ 4 drinks/day), and cigarette smoking, the inverse associations with retinol, β -carotene, and γ -tocopherol remained statistically signifi cant; the adjusted inverse relationship between α -tocopherol and HCC risk was not. Further adjustment for serum levels of β -carotene, α -tocopherol, and γ -tocopherol did not materially change the inverse association between increasing retinol and reduced HCC risk ( P trend <.001, Table 4 ). However, further adjustment for retinol considerably diminished the inverse associations between α -and γ -tocopherols and HCC risk ( P trend = .92 and P trend = .16, respectively). The retinol-adjusted inverse association between increasing β -carotene level and reduced HCC risk remained statistically signifi cant ( P trend = .03).
in men who consumed less than four and four or more drinks of alcoholic beverages per day were similar to that of nondrinkers. However, after adjustment for retinol, the odds ratio for heavy drinkers ( ≥ 4 drinks per day) were statistically signifi cantly different (OR = 2.77, 95% CI = 1.49 to 5.15; P trend = .016) from those of nondrinkers ( Table 1 ) .
Self-reported history of physician-diagnosed hepatitis or liver cirrhosis at baseline was associated with the risk of developing HCC after adjustment for HBsAg seropositivity. Most HCC patients who self reported a history of hepatitis or liver cirrhosis (84%) tested positive for HBsAg, whereas only 45% patients who did not report such a history tested positive. Among control subjects, 20% of those with a history of hepatitis or liver cirrhosis versus 8% of those without a history tested positive for HBsAg. After adjustment for HBsAg seropositivity, selfreported history of hepatitis or liver cirrhosis remained statistically signifi cantly associated with risk of HCC (adjusted OR = 2.95; 95% CI = 1.94 to 4.48). Therefore, both HBsAg seropositivity and self-reported history of hepatitis or liver cirrhosis were included as covariates in all regression models in evaluating the independent effect of micronutrients on HCC risk.
We examined the associations of cigarette smoking, alcohol intake, and chronic HBV infection with circulating levels of micronutrients studied among control subjects only. After adjustment for self-reported history of physician-diagnosed hepatitis or liver cirrhosis, HBsAg-positive subjects had a statistically signifi cantly lower (by 13%) serum retinol level than that of HBsAg-negative subjects ( Table 2 ) . By contrast, regular alcohol drinkers had statistically signifi cantly higher serum level of retinol than that of nondrinkers, whereas smokers and nonsmokers had similar levels of retinol ( Table 2 ) . For other micronutrients studied, smoking was associated with statistically signifi cantly lower levels of α -tocopherol, selenium, and all specifi c carotenoids, except zeaxanthin, whereas alcohol intake was associated with increased levels of lutein. HBsAgpositive subjects had slightly higher levels of β -cryptoxanthin, * Adjusted for age at recruitment (years), years between blood draw and laboratory measurements of serum micronutrients, cigarette smoking (nonsmokers, ever smokers), alcohol intake (nondrinkers, ever drinkers), and self-reported history of physician-diagnosed hepatitis or liver cirrhosis at recruitment (no, yes) as covariates.
† Adjusted for age at recruitment (years), years between blood draw and laboratory measurements of serum micronutrients, cigarette smoking (nonsmokers, ever smokers), self-reported history of physician-diagnosed hepatitis or liver cirrhosis at recruitment (no, yes), and seropositivity for hepatitis B surface antigen (HBsAg) (negative, positive).
‡ Adjusted for age at recruitment (years), years between blood draw and laboratory measurements of serum micronutrients, alcohol intake (nondrinkers, ever drinkers), self-reported history of physician-diagnosed hepatitis or liver cirrhosis at recruitment (no, yes), and seropositivity for HBsAg (no, yes).
§ P values (two-sided) were calculated using analysis of covariance regression models that also included all covariates listed above.
We also examined interactions of serum β -carotene and retinol levels on HCC risk ( Table 5 ) . Within each tertile level of serum retinol, there was no evidence of an association between β -carotene and HCC risk. By contrast, a strong, dose-dependent inverse retinol -HCC risk association (all P trend <.001) was seen within each tertile level of serum β -carotene.
Tertile levels of retinol and HCC risk were then stratifi ed by HBsAg serology and duration of follow-up ( Table 6 ) . A strong, inverse association between prediagnostic serum level of retinol and risk of developing HCC was present independent of HBsAg serology status and duration of follow-up.
We observed an interaction between retinol and HBsAg on HCC risk ( Table 7 ) . Among HBsAg-negative subjects, the lowest tertile level of serum retinol was associated with a fi vefold increased risk of HCC (OR = 4.98, 95% CI = 2.38 to 10.4). Among subjects with the highest tertile of serum retinol, HBsAg seropositivity was associated with a 10-fold increased risk of HCC (OR = 10.6, 95% CI = 3.50 to 32.3). There was evidence of a more than multiplicative interaction between HBsAg seropositivity and serum retinol level on HCC risk. That is, HBsAgpositive subjects in the lowest tertile level of retinol had a greater than 70-fold higher risk of HCC (OR = 72.7, 95% CI = 31.6 to 167.4) than did HBsAg-negative subjects in the highest tertile of retinol ( P interaction = .018).
D ISCUSSION
This study demonstrated a strong inverse association between the concentration of retinol in prediagnostic serum and the risk of developing HCC in middle-aged and older Chinese men in Shanghai, China. The inverse association was present in both HBsAg-positive and -negative men. Furthermore, there was evidence of a more than multiplicative interaction between chronic HBV infection and serum retinol level on HCC risk.
Although most HCC was associated with chronic infection with HBV in our population (61% of case patients tested positive for HBsAg), HCC is not an inevitable consequence of chronic infection with HBV. Only a fraction of chronic HBV carriers eventually develop HCC ( 29 ) , suggesting that other factors contribute to HCC development among chronic carriers of HBV. Previously, we demonstrated a substantial modifying effect of dietary afl atoxin exposure on HBV-related HCC risk in this study population ( 20 , 26 ) . In a previous study ( 13 ) conducted in Guangxi, China, we showed that genetic mutations of cytokine genes played a role in determining individual susceptibility to HBV-related HCC ( 13 ) .
Vitamin A may protect against the development of HCC in humans by controlling hepatocellular differentiation and immunoresponse to viral infection, i.e., HBV. Vitamin A is derived primarily from animal-based food, whereas vegetables and fresh fruit are major sources of provitamin A carotenoids. In humans, the carotenoids possessing provitamin A activity that are present in substantial quantities in the blood include α -carotene, β -carotene, and β -cryptoxanthin. Provitamin A carotenoids can be converted to retinol in vivo. The rate of conversion depends largely on the type and amount of provitamin A carotenoids consumed and the subject's vitamin A status ( 30 ) . A recent study found a mean conversion rate of approximately 9 μ g of β -carotene to 1 μ g of retinol in healthy, well-nourished adults in the United States ( 31 ) . The conversion for α -carotene and β -cryptoxanthin to retinol is less effi cient (approximately half that for β -carotene) ( 32 ) . Whether the measurement of serum retinol levels provides an accurate representation of hepatic levels in well-nourished populations has been debated ( 33 , 34 ) . However, it is widely accepted that there is a direct relationship between serum and hepatic vitamin A levels in vitamin A -defi cient populations ( 33 ) .
Clinical studies have demonstrated that patients with chronic liver diseases have reduced levels of retinol in the blood and in the liver ( 35 , 36 ) . Patients with severe liver cirrhosis have lower serum retinol levels than those with less severe cirrhosis ( 36 ) . Our fi ndings are consistent with these reported data; a statistically signifi cantly lower serum level of retinol was observed among control subjects who were positive for serum HBsAg or had a * Geometric means were calculated using analysis-of-covariance regression models that retained a matched set consisting of fi ve to 10 control subjects who were individually matched to the index case by date of birth (within 2 years), date of blood draw (within 1 month), and neighborhood of residence at recruitment. Covariates were cigarette smoking (nonsmokers, ever smokers), heavy alcohol consumption (nondrinkers or <4 drinks/day, ≥ 4 drinks/day), self-reported history of physiciandiagnosed hepatitis or liver cirrhosis at recruitment (no, yes), and seropositivity for hepatitis B surface antigen (HBsAg) (negative, positive).
† A total of 131 case patients and 104 control subjects who tested positive for HBsAg were excluded from these analyses. The matched case -control sets were not retained in analysis-of-covariance regression models that included age at recruitment (years), years between blood draw and laboratory measurements of serum micronutrients, neighborhood of residence at recruitment, and all other covariates listed above.
‡ P values (two-sided) were calculated by using analysis-of-covariance regression models that also included all covariates listed above.
self-reported history of liver disease (i.e., physician-diagnosed hepatitis or liver cirrhosis). Because reduced serum levels of retinol could be the consequence of HCC or its precursor lesions, it is problematic to assess the etiologic role of retinol in the development of HCC in a retrospective case -control study or in a prospective cohort study with relatively short follow-up. An earlier prospective study of Chinese men showed an inverse relation between baseline serum retinol level and HCC risk. However, that study was based on only 35 patients and a relatively short follow-up (5 years). Moreover, the inverse association was observed in chronic carriers of HBV only ( 37 ) . Nonetheless, given that the liver is the main storage site of vitamin A in vivo and that chronic liver disease is associated with a reduced level of circulating retinol, a noncausal interpretation of the observed retinol -HCC association cannot be completely ruled out. Results from intervention trials would strengthen the evidence for a role of retinol in the etiology of and prevention against HCC in humans. A randomized controlled trial involving 89 HCC patients who were disease free after treatment showed that those who received oral administration of a synthetic retinoid on a daily basis for 12 months had statistically signifi cantly lower incidence of second primary or recurrent HCCs and experienced statistically signifi cantly longer survival than those who received placebo after a median follow-up of 62 months ( 38 , 39 ) . However, there are no intervention trials evaluating the effi cacy of retinol or its derivatives on primary prevention of HCC in humans.
We also examined the associations between serum levels of α -carotene; β -carotene; β -cryptoxanthin; lutein; lycopene; zeaxanthin; and α -, γ -, and δ -tocopherols and HCC risk in this study population. The observed inverse relationships for α -carotene; β -carotene; and α -, γ -, and δ -tocopherols in univariate analyses were explained by cigarette smoking, alcohol drinking, and serum levels of retinol. No independent effect of specifi c † P trend values (two-sided) for micronutrient levels in quartiles were calculated by using conditional logistic regression models that also included all covariates listed above.
‡ Odds ratios were calculated by using conditional logistic regression models that retained a matched set consisting of fi ve to 10 control subjects who were individually matched to the index case patient by date of birth (within 2 years), date of blood draw (within 1 month), and neighborhood of residence at recruitment. § Adjusted for cigarette smoking (nonsmokers, ever smokers), heavy alcohol consumption (nondrinkers or <4 drinks/day, ≥ 4 drinks/day), self-reported history of physician-diagnosed hepatitis or liver cirrhosis at recruitment (no, yes), and seropositivity for hepatitis B surface antigen (negative, positive).
|| Further adjustment for serum levels of β -carotene, α -tocopherol, and γ -tocopherol did not materially change the inverse association between retinol levels and HCC risk ( P trend <.001).
¶ Further adjustment for serum retinol level considerably diminished the inverse relation for HCC risk to α -tocopherol ( P trend = .92) and γ -tocopherol ( P trend = 0.16). However, the retinol-adjusted inverse association between β -carotene level and HCC risk remained statistically signifi cant ( P trend = .03). Table 5 . † The mean time interval between blood draw at recruitment and cancer diagnosis was 6.9 years for all patients, 3.8 years for patients who developed hepatocellular carcinoma (HCC) within 7 years of enrollment, and 10.2 years for patients who developed HCC after 7 years of enrollment.
‡ Odds ratios were calculated by using unconditional logistic regression models that also included age at recruitment (years), years between blood draw and laboratory measurements of serum micronutrients, neighborhood of residence at recruitment, cigarette smoking (nonsmokers, ever smokers), heavy alcohol consumption (nondrinkers or <4 drinks/day, ≥ 4 drinks/day), self-reported history of physician-diagnosed hepatitis or liver cirrhosis (no, yes), and, for total subjects, HBsAg seropositivity (negative, positive).
§ P trend values (two-sided) for retinol level within each category by HBsAg status and duration of follow-up were calculated by using unconditional logistic regression models that also included all covariates listed above. tocopherols and carotenoids on HCC risk was observed, which was consistent with fi ndings from a previous study ( 40 ) .
Dietary supplements with selenium show an inhibitory effect on afl atoxin-induced DNA damage and hepatocarcinogenesis in rats ( 19 , 41 ) but have no effect on incidence of diethylnitrosamine-induced liver cancers ( 42 ) . A study of Chinese men in Taiwan that was based on a small sample size and a relatively short follow-up period reported that patients with HCC had lower levels of serum selenium than those of control subjects ( 43 ) . This study, with a larger sample size and longer follow-up period, did not confi rm these previous results.
Subjects with alcoholic hepatitis had statistically signifi cantly lower levels of hepatic retinol than those with chronic viral hepatitis, although the serum levels of retinol were comparable between the two hepatitis groups ( 44 ) . The total liver vitamin A contents were statistically signifi cantly lower in cirrhotic patients with alcohol abuse than those with hepatitis C infection ( 45 ) . Experimental studies have demonstrated that alcohol intake can enhance mobilization of retinol from the liver to extrahepatic tissues ( 46 ) . A statistically signifi cant increase in circulating retinol level was observed in alcohol drinkers compared with nondrinkers in our study population. Therefore, it is important to adjust for serum retinol levels when assessing the role of alcohol on HCC risk. Here, adjustment for serum retinol levels strengthened the alcohol -HCC association. The depletion of retinol in the liver by alcohol might contribute to * Ca/Co = number of cases patients/number of control subjects. † Odds ratios were calculated by using a conditional logistic regression model that retained a matched set consisting of fi ve to 10 control subjects who were individually matched to the index case patient by date of birth (within 2 years), date of blood collection (within 1 month), and neighborhood of residence at recruitment. The conditional logistic regression model also included cigarette smoking (nonsmokers, ever smokers), heavy alcohol consumption (nondrinkers or <4 drinks/day, ≥ 4 drinks/day), self-reported history of physician-diagnosed hepatitis or liver cirrhosis at recruitment (no, yes), and seropositivity for hepatitis B surface antigen (negative, positive).
‡ P trend values (two-sided) for retinol (or β -carotene) level within each tertile level of β -carotene (or retinol) were calculated by using unconditional logistic regression models that also included age at recruitment (years), years between blood draw and laboratory measurements of serum micronutrients, neighborhood of residence at recruitment, and all covariates listed above.
alcohol-induced hepatocarcinogenesis. Low retinol intake could exacerbate the effect of alcohol on HCC risk in heavy alcohol drinkers.
Our study had several strengths. The prospective study design and the availability of prediagnostic serum specimens minimized the possible infl uence of disease symptoms on dietary intake of various micronutrients and other lifestyle factors. The measurements of multiple serum micronutrients allowed for simultaneous evaluations of the relationships between measured micronutrients and HCC risk.
Our study also had several limitations. Although the study was based on a cohort of more than 18 000 Chinese men with 15 years of follow-up, the number of incident HCC case patients was relatively small, and hence confi dence intervals for the interaction between retinol level and HBsAg on HCC risk were wide. Another limitation was that the assessment of serum micronutrients was conducted at baseline serum samples only. Changes in diet during the course of follow-up were not captured. However, dietary changes leading to either increasing or decreasing intakes of micronutrients, when they occurred equally in both case patients and control subjects, would shift the estimated odds ratios toward 1.0 (i.e., null effect). Thus the failure of this study to detect a statistically signifi cant association between carotenoids, tocopherols, or selenium and HCC risk could be due to this limitation, especially when the true effect of these micronutrients on disease risk is moderate.
In summary, this study demonstrates that higher prediagnostic serum levels of retinol was associated with statistically significantly reduced risk of developing HCC in middle-aged or older Chinese men in Shanghai, China. The association between serum retinol levels and HCC risk was present in both chronic carriers and noncarriers of HBV. There is a statistically signifi cant interaction between low retinol levels and HBsAg positivity on HCC risk. Given that HCC is a highly fatal malignancy, our fi ndings may have clinical and prevention implications.
